NO20010116L - Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild - Google Patents

Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild

Info

Publication number
NO20010116L
NO20010116L NO20010116A NO20010116A NO20010116L NO 20010116 L NO20010116 L NO 20010116L NO 20010116 A NO20010116 A NO 20010116A NO 20010116 A NO20010116 A NO 20010116A NO 20010116 L NO20010116 L NO 20010116L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
preparation containing
antiviral agent
containing gaba
gaba analogues
Prior art date
Application number
NO20010116A
Other languages
English (en)
Other versions
NO20010116D0 (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010116L publication Critical patent/NO20010116L/no
Publication of NO20010116D0 publication Critical patent/NO20010116D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20010116A 1998-07-09 2001-01-08 Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild NO20010116D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (2)

Publication Number Publication Date
NO20010116L true NO20010116L (no) 2001-01-08
NO20010116D0 NO20010116D0 (no) 2001-01-08

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010116A NO20010116D0 (no) 1998-07-09 2001-01-08 Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild

Country Status (17)

Country Link
EP (1) EP1093366B1 (no)
JP (1) JP2002520300A (no)
KR (1) KR20010071776A (no)
AT (1) ATE279188T1 (no)
AU (1) AU765246B2 (no)
CA (1) CA2332929C (no)
DE (1) DE69921137T2 (no)
DK (1) DK1093366T3 (no)
ES (1) ES2230863T3 (no)
ID (1) ID27395A (no)
NO (1) NO20010116D0 (no)
NZ (2) NZ508489A (no)
PL (1) PL345337A1 (no)
PT (1) PT1093366E (no)
SI (1) SI1093366T1 (no)
WO (1) WO2000002592A1 (no)
ZA (1) ZA200007169B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541215A (ja) 1999-04-09 2002-12-03 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬組成物およびその使用
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DE60209152T2 (de) 2001-09-03 2006-08-03 Newron Pharmaceuticals S.P.A. Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
RS54522B1 (en) 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
AU731279B2 (en) * 1996-03-14 2001-03-29 Warner-Lambert Company Novel bridged cyclic amino acids as pharmaceutical agents
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
DE69921137T2 (de) 2006-02-02
ZA200007169B (en) 2002-03-04
ID27395A (id) 2001-04-05
EP1093366A1 (en) 2001-04-25
PL345337A1 (en) 2001-12-17
CA2332929A1 (en) 2000-01-20
ATE279188T1 (de) 2004-10-15
NZ525623A (en) 2005-08-26
AU4701699A (en) 2000-02-01
PT1093366E (pt) 2005-02-28
CA2332929C (en) 2005-05-31
AU765246B2 (en) 2003-09-11
DK1093366T3 (da) 2004-12-06
JP2002520300A (ja) 2002-07-09
NO20010116D0 (no) 2001-01-08
WO2000002592A1 (en) 2000-01-20
NZ508489A (en) 2004-06-25
SI1093366T1 (en) 2005-02-28
EP1093366B1 (en) 2004-10-13
KR20010071776A (ko) 2001-07-31
ES2230863T3 (es) 2005-05-01
DE69921137D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
NO2008018I2 (no) (3S)-3-(Aminometyl)-5-metylheksansyre (Pregabalin)eller et farmasøytisk akseptabelt salt derav
IS2749B (is) Ný tegund af lyfjablöndu
IS2706B (is) Lyfjasamsetning sem inniheldur róteindadæluhindra
BR9809292A (pt) Métodos aperfeiçoados para o processamento de proteìna c ativada
NO20010116L (no) Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild
DK0994704T3 (da) Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme
ID27818A (id) Metode untuk menyediakan glutamin
ATE305778T1 (de) Behandlung von nierenkolik mit gaba-analogen
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
BRPI0502744A (pt) processo para reduzir a atividade do ativador de pré-calicreìna (pka) em soluções de albumina purificada de origem humana e para estabilizá-la temporalmente; processo para obter albumina; e solução purificada de albumina de origem humana com baixa atividade do ativador de pré-calicreìna (pka) e com estabilidade temporal
KR950700685A (ko) 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac)
BR9809498A (pt) Composto, processo para sua produção, composição farmacêutica, processo para sua produção, e processos para tratamento de infecção pelo hiv, para tratamento da aids, para inibição de uma hiv protease, e, para produzir um solvato de etanolato.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application